Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_assertion type Assertion NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_head.
- NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_assertion description "[Performance characteristics of ISH and HC2 were compared in 99 consecutive cervical cytology samples diagnosed as low grade squamous intraepithelial lesion and processed by either the ThinPrep (Cytyc Corporation, Boxborough, Massachusetts, U.S.A.) or SurePath (TriPath Imaging Systems, Research Triangle Park, North Carolina, U.S.A.) method at 2 geographically different centers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_provenance.
- NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_assertion evidence source_evidence_literature NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_provenance.
- NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_assertion SIO_000772 15839613 NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_provenance.
- NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_assertion wasDerivedFrom befree-20140225 NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_provenance.
- NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_assertion wasGeneratedBy ECO_0000203 NP186263.RAd_-DXc51xm1MybcVkCS2ol82cwyyt7Ra2g1LUdUmbfg130_provenance.